FRIDAY, April 27 (HealthDay News) -- The U.S. Food and Drug
Administration on Friday announced that it had approved Stendra, a
new medication for erectile dysfunction.
Stendra (avanafil) joins Viagra, Cialis and Levitra, all from a
class of drugs known as phosphodiesterase type 5 inhibitors that
help boost blood flow to the penis.
According to the FDA, fast-acting Stendra is designed to be
taken 30 minutes before sexual activity and at the lowest effective
Whether the new drug adds any value to the existing range of
impotence medications is unclear, one expert said.
Dr. Bruce Kava, acting chairman of urology at the University of
Miami School of Medicine, said that "the only advantage Stendra may
have is a more rapid onset of action over the other drugs. The
question is whether there are any advantages to a more rapid
He noted that many patients don't respond to one or another of
these drugs. But there is no way right now of telling who will
respond to which drug. "Sometimes it's hit or miss," he
Men will have to try these drugs to find the one that best suits
their lifestyle, Kava said. For example, for some men Cialis works
best because its effects seem to last much longer than that of the
other drugs, he said.
The FDA said Stendra's approval means one more option for
"This approval expands the available treatment options to men experiencing erectile dysfunction, and enables patients, in consultation with their doctor, to choose the most appropriate treatment for their needs," Dr. Victoria Kusiak, deputy director of the Office of Drug Evaluation III in the FDA's Center for Drug Evaluation and Research, said in a statement.
Stendra comes with the same warnings as its companions in this
drug class. It should not be taken by men who take nitrates --
drugs used to treat chest pain (angina). This combination can cause
a sudden drop in blood pressure, the FDA cautioned.
The agency also warned that these drugs can, in rare cases,
cause color vision changes and in rare instances, men have also
reported a sudden loss of vision in one or both eyes. Sudden loss
or decrease in hearing has also been reported in patients taking
these drugs. "Patients who experience a sudden loss of vision or
hearing should stop taking PDE5 inhibitors, including Stendra, and
call a doctor right away," the FDA said.
The most common side effects reported with Stendra include
headache, redness of the face and other areas, nasal congestion,
cold-like symptoms and back pain.
In rare cases, patients taking these drugs may get an erection
lasting four hours or longer that will not go away. "If this
happens, patients should seek immediate medical care," the agency
Erectile dysfunction occurs when a man has trouble getting or
maintaining an erection. An estimated 30 million American men in
are affected by erectile dysfunction, according to the FDA.
Stendra's safety and efficacy were established in three
double-blind, placebo-controlled clinical studies. A total of 1,267
patients were randomly assigned to take Stendra for up to 12 weeks
at doses of 50 milligrams (mg), 100 mg or 200 mg, or a placebo as
needed about 30 minutes before sexual activity.
Stendra is marketed by Mountain View, Calif.-based Vivus
For more information on erectile dysfunction, visit the
U.S. National Library of Medicine.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.